Join the UCSF Rosenman Institute as we sit down with the most inspiring innovators in the healthtech industry. Our guests are creating technologies that save and improve patients’ lives. Listen in as they share their journeys, career insights, and invaluable lessons learned. Be inspired by the best and brightest in healthtech as they discuss their contributions to the future of healthcare.
Episodes
Friday Nov 09, 2018
Friday Nov 09, 2018
Derek Herrera, Founder & CTO, Spinal Singularity
Former Marine Special Operations Officer now working to create change as an entrepreneur in the medical device Industry. Passionate about utilizing advanced technology to create meaningful products to improve people's lives.
An ethical, hard-working leader with proven performance in building successful teams able to accomplish the most challenging of missions in austere, kinetic environments. Demonstrated capacity in building teams across multiple functional areas. Excels at strategic planning, problem framing, and identifying innovative solutions.
Friday Nov 09, 2018
Friday Nov 09, 2018
Adam Schoen, Partner, Brown Rudnick
Adam Schoen advises life science and medical device companies regarding implementation of a patent strategy to further business objectives and business goals. Adam’s practice encompasses patent preparation and prosecution, portfolio development, product clearance, freedom to operate analysis and intellectual property due diligence. Adam works with public and private companies, investors, and academic institutions.
Adam has experience with a variety of technologies, such as next generation sequencing technologies, droplet based technologies, cancer diagnostics, medical device technology (ophthalmology, cardiology, orthopedics, neurology, spine) and medical imaging technology (IVUS and OCT), mass spectrometry, small molecule therapeutics, digital health, near field communication technology, and semiconductor technology. He manages patent portfolios of all sizes and develops strategies to maximize and protect intellectual property rights in both the United States and foreign jurisdictions.
Prior to law school, Adam was a scientist of analytical chemistry for ArQule Inc., a combinatorial chemistry and drug discovery company.